Calidi Biotherapeutics, Inc. CLDI
Set alert
0.69 USD +0.02 +2.43%
At close · Oct 30
0.71 +0.02 +2.95%
After hours · Oct 30, 6:15 PM ET
0.65 Day range 0.688
0.64 52-week range 26.56
- YTD
- -96.32%
- 1 year
- -97.28%
- Open
- 0.667
- Prev close
- 0.6717
- Mkt cap
- 2.53M
- Vol
- 48.42K
- Avg vol
- 141.28K
- EPS
- -36.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.65
- High
- 0.688
- Forward P/E
- -1.57
- Beta
- 0.57
- Short ratio
- 0.88
- Inst. own
- 2.71%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.67
- 200-d avg
- 2.22
- 1y target
- 6.25
Financial health
Altman Z-Score
-36.44 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -0.2×
FY 2020 5y median -0.4× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 1.3×
FY 2020 5y median -1.7× FY 2025
P/FCF -0.2×
FY 2020 5y median -0.9× FY 2025
EV/EBITDA -0.1×
FY 2020 5y median -1.3× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -425.4%
FY 2020 5y median -108.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -529.6%
FY 2020 5y median 48.4% FY 2025
ROIC -314.4%
FY 2020 5y median -238.5% FY 2025
ROA -224.7%
FY 2020 5y median -291.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 7.1%
FY 2020 FY 2025
EPS (diluted) 83.3%
FY 2020 FY 2025
Free Cash Flow -8.6%
FY 2020 FY 2025
Financial Health
Current Ratio 1.6×
FY 2020 5y median 0.4× FY 2025
Quick Ratio 1.6×
FY 2020 5y median 0.4× FY 2025
Debt / Equity 0.7×
FY 2020 5y median -0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2020 5y median -0.2× FY 2025
Interest Coverage -97.8×
FY 2020 5y median -23.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31